Member Info for doze

Cancer Research UK seem to have been soaking up funds forever and still rely on chemo, perhaps AVCT can help out especially with a leg up like with the LFT.

lead the world in life sciences pioneering new treatments against diseases like cancer-in The Queens speech 11.37 am

entelon-your point'Throughout, Johnson will be able to lay some responsibility upon the public to take the new, heavily HMG sponsored LFTs seriously.' is v much my opinion too as that might be crucial for validating AffiDX for oversea sales. It will be difficult with pandemic deniers being quite thick on the ground however school/university outbreaks would ram home his message.
I hope this new Indian variant, if reports are correct that it heads straight for the lungs, will neverteless be detectable with affimers as the virus has to be breathed out to spread. An instruction on the box should include-breathe in through the mouth and out through the nose three times while the swab is in AN position, then withdraw, aswell as the twizzling bit.

Within the consortium the 'Authority' needs to contract directly with the members hence the IP clauses but I don't think the Government will be making tests for the Commonwealth but AVCT might.

Mologic named again in 3.7, they must already be in a published contract.

Livedataaccount-re 16.37 post, I thought the government would have PD CV for affimers under non disclosure but this redaction will cover them ahead of AVCT gaining ISO 13485 and using our Spanish CV

Certainly encouraging re the volume they imagine for the industry. There will be many suggestions these consultants will be able to make at ABD/ODX/GAD and maybe even BBI but £1m will not stretch to production line equipment imo but only the right advice on what should be bought and oversight of installation.

All sorts of provisos scaredy to stop del boy applications, hopefully we have already bypassed participation.

Within the consortium the sovereign test can use the ISO/CEmark or whatever else of its members to bring out the LFT at cost but AVCT need all their own to market AffiDX.

AVCT cannot go commercial until they have the certificate so no AffiDX until the 6-8 weeks is over but I don't know when that started. All strikes me AS playing catch up since he decided to be a manufacturing outsourcer and take more of the margin for AVCT.

I find myself getting lax over masks and distance but would not put myself in that situation if I had a positive LFT. The lifting of lockdown event attendance requires advanced confirmation of negative LFD and tests for 7 days thereafter if someone was positive at the event. Those are not with the shoebox.

They are the centre of the northern powerhouse I believe to be joined by AS if they can whip him into shape.

No, I'm not on social media. It is jackester who doesn't believe you!

I didn't know Hughes was a founder director and shareholder of Boohoo so obviously he will get on very well with Kamani and will have more patience than most of us for Medusa 19 to come good.

Its a reverse ramp

Medusa19 have a profit sharing contract with us to supply AffiDX exclusively to individuals and businesses
"he Group has agreed an exclusive distribution agreement with Medusa19 for the supply of the COVID-19 rapid test direct to consumers globally, subject to the necessary regulatory approvals. Medusa19 has been established by Richard Hughes and Mahmud Kamani, both founder shareholders of Boohoo.com and shareholders of Avacta1, to build a global consumer self-testing business. Medusa19's initial focus will be on COVID-19 home testing and it is currently investing in global e-commerce, logistics and customer support infrastructure in preparation for Avacta's COVID-19 test launch. Medusa19 will also have non-exclusive rights to supply the tests to businesses for workforce testing. The distribution agreement includes a profit-sharing arrangement." https://www.lse.co.uk/rns/AVCT/distribution-agreement-for-covid-19-antigen-test-21mboh9bzzm6j5g.html
The fact they obviously still working well together implies they are still OK iro Medusa19

perfection can be a killer

The entrepreneurs are working together again
https://www.lse.co.uk/rns/LSAI/proposed-fundraise-of-up-to-163385m-notice-of-gm-5ss14t9p6guyg71.html

Higher take up in the US has meant investing in BIRD at a higher p/e with their appetite for tech and news channels/journalists know how to spread good news re editing.

"no discernible difference in performance when using frozen samples", don't know if this is new wording in the protocol;Bell sticking with his method

https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/protocol-for-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices

lyttonwolf's link
https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices

The negatives will be fresh samples, transported within 48 hours, the positives will be frozen. This follows recent work at PHE Porton Down to support the development of this protocol which found there to be no discernible difference in performance when using frozen samples.
Additionally, samples from people from PCR-confirmed positive cases identified by the Lighthouse Laboratories will be tested both ‘in the field’ and subsequently by PHE Porton Down. Wherever possible, at least 2 products will be evaluated side-by-side in phase 3 to ensure most efficient use of time and resources.